Patents by Inventor Thierry Coche

Thierry Coche has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method for the detection and diagnosis of cancer involving primers and probes for the specific detection of the MAGE-A3-marker
    Patent number: 8936919
    Abstract: The present invention relates to MAGE-3 specific primers and probes for use new diagnostic kits and methods. The invention further relates to immunotherapeutic treatment of specific populations of cancer patients, suffering from MAGE-3 expressing tumors.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: January 20, 2015
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Gabriele Annemarie Beer, Thierry Coche, Olivier Gruselle, Dennis Salonga, Craig Lawrence Stephens
  • Tumor specific animal proteins
    Patent number: 8535690
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: May 15, 2012
    Date of Patent: September 17, 2013
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • TUMOR SPECIFIC ANIMAL PROTEINS
    Publication number: 20120244175
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: May 15, 2012
    Publication date: September 27, 2012
    Inventors: Teresa Elisa Virginia CABEZON-SILVA, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Patent number: 8207123
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 20, 2010
    Date of Patent: June 26, 2012
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Method for the Detection and Diagnosis of Cancer Involving Primers and Probes for the Specific Detection of the MAGE-A3-Marker
    Publication number: 20120040341
    Abstract: The present invention relates to MAGE-3 specific primers and probes for use new diagnostic kits and methods. The invention further relates to immunotherapeutic treatment of specific populations of cancer patients, suffering from MAGE-3 expressing tumours.
    Type: Application
    Filed: June 21, 2007
    Publication date: February 16, 2012
    Inventors: Gabriele Annemarie Beer, Thierry Coche, Olivier Gruselle, Dennis Salonga, Craig Lawrence Stephens
  • TUMOUR-SPECIFIC ANIMAL PROTEINS
    Publication number: 20110052615
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: August 20, 2010
    Publication date: March 3, 2011
    Inventors: TERESA ELISA VIRGINIA CABEZON-SILVA, JEAN-POL CASSART, THIERRY COCHE, SWANN ROMAIN JEAN-THOMAS GAULIS, CARLOTA VINALS Y DE BASSOLS
  • Tumour-Specific Animal Proteins
    Publication number: 20100291121
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: March 9, 2009
    Publication date: November 18, 2010
    Inventors: Jean-Pol Cassart, Teresa Elisa Virginia Cabezon-Silva, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Patent number: 7811574
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 28, 2003
    Date of Patent: October 12, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Jean-Pol Cassart, Teresa Elisa Virginia Cabezon-Silva, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Method for Classifying Cancer Patients as Responder or Non-Responder to Immunotherapy
    Publication number: 20100247580
    Abstract: The present invention relates to gene expression profiles; methods for classifying patients; microarrays; and treatment of population of patients selected through use of methods and microarrays as described herein.
    Type: Application
    Filed: November 27, 2008
    Publication date: September 30, 2010
    Inventors: Thierry Coche, Swann Gaulis, Jamila Louahed
  • Tumour-specific animal proteins
    Patent number: 7803379
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: December 13, 2005
    Date of Patent: September 28, 2010
    Assignee: GlaxoSmithKline Biologicals S.A.
    Inventors: Teresa Elisa Virginia Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Method For Identifying Whether A Patient Will Be Responder or Not to Immunotherapy
    Publication number: 20100021424
    Abstract: The present invention relates to gene expression profiles, microarrays comprising nucleic acid sequences representing gene expression profiles and new diagnostic kits and methods. The invention further relates to treatment of specific populations of, for example, cancer patients, as characterised by their gene expression profile, suffering from Mage expressing tumours.
    Type: Application
    Filed: May 31, 2007
    Publication date: January 28, 2010
    Inventors: Vincent Brichard, James Scott Clark, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Olivier Gruselle, Frederic Lehmann, Jamila Louahed
  • CASB618 Polynucleotides and Polypeptides and Their Use
    Publication number: 20090202577
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: November 21, 2008
    Publication date: August 13, 2009
    Inventors: CLAUDINE ELVIRE BRUCK, JEAN-POL CASSART, THIERRY COCHE, CARLOTA VINALS Y DE BASSOLS
  • CASB618 polynucleotides and polypeptides and their use
    Patent number: 7470782
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Grant
    Filed: August 9, 2005
    Date of Patent: December 30, 2008
    Assignee: GlaxoSmithKline Biologicals, S.A.
    Inventors: Claudine Elvire Marie Bruck, Jean-Pol Cassart, Thierry Coche, Carlota Vinals Y De Bassols
  • Cripto tumour polypeptide
    Patent number: 7439320
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.
    Type: Grant
    Filed: August 20, 2001
    Date of Patent: October 21, 2008
    Assignee: GlaxoSmith Kline Biologicals s.a.
    Inventors: Jean-Pol Cassart, Thierry Coche, Remi M Palmantier, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Publication number: 20060171953
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: December 13, 2005
    Publication date: August 3, 2006
    Inventors: Teresa Cabezon-Silva, Jean-Pol Cassart, Thierry Coche, Swann Romain Gaulis, Carlota Vinals Y De Bassols
  • CASB618 polynucleotides and polypeptides and their use
    Publication number: 20060052593
    Abstract: CASB618 polypeptides and polynucleotides and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB618 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: August 9, 2005
    Publication date: March 9, 2006
    Inventors: Claudine Bruck, Jean-Pol Cassart, Thierry Coche, Carlota Vinals Y De Bassols
  • Tumour-specific animal proteins
    Publication number: 20040141988
    Abstract: CASB7439 polypeptides and polynucleotides, immunogenic compositions comprising them and methods for producing such polypeptides by recombinant techniques are disclosed. Also disclosed are methods for utilizing CASB7439 polypeptides and polynucleotides in diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly colorectal, breast, and lung cancers, autoimmune diseases, and related conditions.
    Type: Application
    Filed: August 28, 2003
    Publication date: July 22, 2004
    Inventors: Jean-Pol Cassart, Teresa Elisa Virginia Cabezon-Silva, Thierry Coche, Swann Romain Jean-Thomas Gaulis, Carlota Vinals Y De Bassols
  • Vaccines
    Publication number: 20040138112
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.
    Type: Application
    Filed: April 4, 2003
    Publication date: July 15, 2004
    Inventors: Jean-Pol Cassart, Thierry Coche, Remi M. Palmantier, Carlota Vinals Y De Bassols
  • Cripto tumour polypeptide
    Publication number: 20040054142
    Abstract: Compositions and methods for the therapy and diagnosis of cancer, particularly lung, colon, colorectal and breast cancer, are disclosed. Illustrative compositions comprise one or more Cripto tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. The disclosed compositions are useful, for example, in the diagnosis, prevention and/or treatment of diseases, particularly lung, colon, colorectal and breast cancer.
    Type: Application
    Filed: August 4, 2003
    Publication date: March 18, 2004
    Inventors: Jean-Pol Cassart, Thierry Coche, Remi M Palmantier, Carlota Vinals Y De Bassols
  • Component of a modular system for vertical hydroponics
    Patent number: D854649
    Type: Grant
    Filed: January 3, 2017
    Date of Patent: July 23, 2019
    Inventor: Thierry Coche